PHSE
Pharmhouse Corp
0.0099$
+23.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| – | – | – | – | – | – | – | – | 21.2% | 22.9% | 23.8% | 24.7% | 23.4% | |
| – | – | – | – | – | – | – | – | 78.8% | 77.1% | 76.2% | 75.3% | 76.6% | |
| – | – | – | – | – | – | – | – | 124.8% | 486.3% | 204.5% | 148.4% | 261.4% | |
| – | – | – | – | – | – | – | – | -46.0% | -409.2% | -128.3% | -73.2% | -184.8% | |
| – | – | – | – | – | – | – | – | 4.3% | 0.8% | 0.1% | 8.5% | 3.1% | |
| – | – | – | – | – | – | – | – | -50.4% | -407.6% | -142.2% | -81.7% | -191.1% | |
| – | – | – | – | – | – | – | – | -50.4% | -423.7% | -142.2% | -81.7% | -195.9% | |
| – | – | – | – | – | – | – | – | -46.0% | -409.2% | -125.4% | -69.9% | -183.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.